Meeting
2022 ASCO Annual Meeting
Estimating the impact of reducing the age of colorectal cancer screening on cancer incidence, mortality, and costs in Canada using OncoSim.
Authors
Anastasia Kalyta
University of British Columbia Faculty of Medicine, Vancouver, BC, Canada
Anastasia Kalyta , Jonathan M. Loree , Mary A. De Vera , Stuart Peacock , Jennifer J. Telford , Carl J Brown , Fergal Donnellan , Sharlene Gill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3526)
DOI
10.1200/JCO.2022.40.16_suppl.3526
Abstract #
3526
Poster Bd #
320
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
To screen or not to screen: Colonoscopy, a story of successful population-based screening.
First Author: Catalina Mosquera
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of revising colorectal cancer screening guidelines on health care resources in Canada.
First Author: Brendan Chia
Poster
2023 ASCO Annual Meeting
The impact of extending CRC screening to the older population: Results from CRC-AIM microsimulation model.
First Author: Derek W. Ebner
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Cost effectiveness of liquid biopsy for colorectal cancer screening.
First Author: Zainab Aziz